Aviceda Therapeutics logo
Healthcare & Life Sciences

Aviceda Therapeutics

Cambridge, United Statesavicedarx.com

Aviceda Therapeutics is a Healthcare & Life Sciences startup based in Cambridge, the United States, most recent round Series C+, 1 tracked investor.

Activeseries-c-plus
series-c-plus
Stage
1
Investors

About Aviceda Therapeutics

Aviceda Therapeutics is a company headquartered in Cambridge, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Aviceda Therapeutics develops novel glyco-immune checkpoint therapeutics aimed at treating immune-mediated diseases, with a focus on macular degeneration to prevent blindness.

Explore Aviceda Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States